PT91836A - Processo para a preparacao de composicoes farmaceuticas contendo pteridinas, apropriadas para evitar a resistencia primaria e secundaria na quimioterapia, e denovas pteridinas - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo pteridinas, apropriadas para evitar a resistencia primaria e secundaria na quimioterapia, e denovas pteridinas

Info

Publication number
PT91836A
PT91836A PT91836A PT9183689A PT91836A PT 91836 A PT91836 A PT 91836A PT 91836 A PT91836 A PT 91836A PT 9183689 A PT9183689 A PT 9183689A PT 91836 A PT91836 A PT 91836A
Authority
PT
Portugal
Prior art keywords
pteridines
group
preparation
chemotherapy
pteridinas
Prior art date
Application number
PT91836A
Other languages
English (en)
Other versions
PT91836B (pt
Inventor
Armin Heckel
Jorg Lebsanft
Uwe Bamberger
Arner Ramu
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PT91836A publication Critical patent/PT91836A/pt
Publication of PT91836B publication Critical patent/PT91836B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT91836A 1988-10-01 1989-09-28 Processo para a preparacao de composicoes farmaceuticas contendo pteridinas, apropriadas para evitar a resistencia primaria e secundaria na quimioterapia, e denovas pteridinas PT91836B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
PT91836A true PT91836A (pt) 1990-04-30
PT91836B PT91836B (pt) 1995-07-18

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91836A PT91836B (pt) 1988-10-01 1989-09-28 Processo para a preparacao de composicoes farmaceuticas contendo pteridinas, apropriadas para evitar a resistencia primaria e secundaria na quimioterapia, e denovas pteridinas

Country Status (19)

Country Link
EP (1) EP0362645B1 (pt)
JP (1) JPH02256676A (pt)
KR (1) KR910006289A (pt)
AT (1) ATE106728T1 (pt)
AU (1) AU620645B2 (pt)
DD (1) DD299062A5 (pt)
DE (2) DE3833393A1 (pt)
DK (1) DK480489A (pt)
ES (1) ES2056174T3 (pt)
FI (1) FI92699C (pt)
HU (1) HU205761B (pt)
IL (1) IL91814A (pt)
MX (1) MX9203034A (pt)
NO (1) NO175979C (pt)
NZ (1) NZ230833A (pt)
PT (1) PT91836B (pt)
SU (1) SU1720491A3 (pt)
UA (1) UA8028A1 (pt)
ZA (1) ZA897414B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69920757T2 (de) * 1998-12-28 2005-12-15 4 AZA Bioscience N.V. Immunosuppressive wirkungen von pteridinderivaten
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
PT1663244E (pt) * 2003-09-12 2007-11-15 4 Aza Ip Nv Derivados de ptiridina para o tratamento de doenças relacionadas com o tnf-alfa
EP1673092B1 (en) * 2003-10-17 2007-08-15 4 Aza Ip Nv Heterocycle-substituted pteridine derivatives and their use in therapy
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
US9259426B2 (en) 2006-07-20 2016-02-16 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
SI3321265T1 (sl) 2015-03-04 2020-07-31 Gilead Sciences, Inc. Spojine 4,6-diamino-pirido(3,2-d)pirimidina in njihova uporaba kot modulatorji toličnih receptorjev
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
MA46093A (fr) 2016-09-02 2021-05-19 Gilead Sciences Inc Composés modulateurs du recepteur de type toll
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (pt) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
JPH02256676A (ja) 1990-10-17
ATE106728T1 (de) 1994-06-15
FI92699C (fi) 1994-12-27
DE3833393A1 (de) 1990-04-05
EP0362645B1 (de) 1994-06-08
DE58907824D1 (de) 1994-07-14
NO893879L (no) 1990-04-02
AU4174989A (en) 1990-04-05
NO175979B (no) 1994-10-03
EP0362645A2 (de) 1990-04-11
FI92699B (fi) 1994-09-15
FI894615A0 (fi) 1989-09-29
IL91814A (en) 1994-02-27
IL91814A0 (en) 1990-06-10
EP0362645A3 (de) 1992-03-25
PT91836B (pt) 1995-07-18
AU620645B2 (en) 1992-02-20
HU205761B (en) 1992-06-29
DD299062A5 (de) 1992-03-26
HUT52504A (en) 1990-07-28
NZ230833A (en) 1991-05-28
DK480489A (da) 1990-04-02
FI894615A (fi) 1990-04-02
DK480489D0 (da) 1989-09-29
NO893879D0 (no) 1989-09-29
NO175979C (no) 1995-01-11
ES2056174T3 (es) 1994-10-01
MX9203034A (es) 1992-07-01
SU1720491A3 (ru) 1992-03-15
KR910006289A (ko) 1991-04-29
ZA897414B (en) 1991-06-26
UA8028A1 (uk) 1995-12-26

Similar Documents

Publication Publication Date Title
PT91836A (pt) Processo para a preparacao de composicoes farmaceuticas contendo pteridinas, apropriadas para evitar a resistencia primaria e secundaria na quimioterapia, e denovas pteridinas
DE3669503D1 (de) Oberflaechenaktive n-(omega, omega-1-dialkoxy)- und n-(omega, omega-1-dialkenoxy)-alk-1-yl-n,n,n-trisubstituierte ammoniumverbindungen, deren herstellung und sie enthaltende pharmazeutische formulierungen.
ES8707514B9 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
IE821768L (en) Pyrrolidine derivatives
ES8706608A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
DE3882438D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
SE314986B (pt)
ATE1672T1 (de) In 4-stellung substituierte 1-(aminoalkylamino)5,8-dihydroxy-anthrachinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen dieser verbindungen.
ES345993A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES8403853A1 (es) Procedimiento para la fabricacion de nuevos derivados aminoalquil naftalenicos.
ES331427A1 (es) Procedimiento para la preparacion de nuevos compuestos heterociclicos condensados.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
ES291187A1 (es) Un procedimiento para preparar piperazinas sustituidas
ES345992A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
GB880334A (en) New hydrazinium compounds, their production and pharmaceutical compositions containing them
GB1085922A (en) Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
GB1157246A (en) Dibenzothiepin Derivatives and their preparation
GB1045657A (en) Dialkylaminoalkyl estrone oxime derivatives
ES252697A1 (es) Procedimiento para la obtenciën de nuevos derivados de fenociatina
SE317382B (pt)
GB1085101A (en) Substituted oxomorphanthridines
GB1074196A (en) Asymmetrical di-n-substituted piperazines and process for their manufacture

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960930